dianhydrogalactitol has been researched along with maytansine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, SK | 1 |
| Fan, YJ; Li, M; Zhou, J | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
1 review(s) available for dianhydrogalactitol and maytansine
| Article | Year |
|---|---|
New drugs under clinical evaluation in the United States.
Topics: Aldehydes; Altretamine; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carmustine; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Humans; Ifosfamide; Maytansine; Streptozocin; Tegafur; Trichothecenes | 1978 |
2 other study(ies) available for dianhydrogalactitol and maytansine
| Article | Year |
|---|---|
[Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dianhydrogalactitol; Hematopoietic Stem Cells; Maytansine; Mice; Neoplasms, Experimental; Oxazines; Sugar Alcohols | 1983 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |